Class IIReported 2025-07-02

Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112

Recalled by Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

Reason for Recall

Lack of Assurance of Sterility

Recall Number

D-0482-2025

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-05-21

Reported

2025-07-02

Distribution

USA Nationwide

Code Info

Lot, expiry: H272962, exp 12/5/2025; S5045185, exp 5/20/2025; H272962, exp 12/5/2025; H270625, exp 9/30/2025

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.